Overview
Pengfei Zhang practices practicing medicine in Changsha, China.
Zhang is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Lung Adenocarcinoma, Lung Cancer, and Squamous Cell Lung Carcinoma.
They are actively involved in clinical research, co-authoring 23 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Pengfei Zhang
Is Pengfei Zhang a top-rated expert for Lung Adenocarcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Pengfei Zhang is classified as an Advanced expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Pengfei Zhang participate in research or clinical trials?
Yes. Pengfei Zhang has published 23 articles and abstracts on conditions like Lung Adenocarcinoma. You can view a list of Pengfei Zhang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung AdenocarcinomaZhang isAdvanced. Learn about Lung Adenocarcinoma.
- Experienced
- Lung CancerZhang isExperienced. Learn about Lung Cancer.
- Squamous Cell Lung CarcinomaZhang isExperienced. Learn about Squamous Cell Lung Carcinoma.